相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis
Mohammed Tarique et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)
Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues
Liguo Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
COVIDium: a COVID-19 resource compendium
Rohit Satyam et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2021)
The Architecture of SARS-CoV-2 Transcriptome
Dongwan Kim et al.
CELL (2020)
Estimating The Infection Fatality Rate Among Symptomatic COVID-19 Cases In The United States
Anirban Basu
HEALTH AFFAIRS (2020)
World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)
Catrin Sohrabi et al.
INTERNATIONAL JOURNAL OF SURGERY (2020)
International Expansion of a Novel SARS-CoV-2 Mutant
Minjin Wang et al.
JOURNAL OF VIROLOGY (2020)
Aerosol transmission of SARS-CoV-2? Evidence, prevention and control
Song Tang et al.
ENVIRONMENT INTERNATIONAL (2020)
Global perspective of COVID-19 epidemiology for a full-cycle pandemic
John P. A. Ioannidis
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)
Safety of foods, food supply chain and environment within the COVID-19 pandemic
Myrto Rizou et al.
TRENDS IN FOOD SCIENCE & TECHNOLOGY (2020)
Collaborated effort against SARS-CoV-2 outbreak in China
Qiwen Yang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target
Serdar Durdagi
TURKISH JOURNAL OF BIOLOGY (2020)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Randomized Phase II Trial of the Cyclin-Dependent Kinase Inhibitor Dinaciclib (MK-7965) Versus Capecitabine in Patients With Advanced Breast Cancer
Monica M. Mita et al.
CLINICAL BREAST CANCER (2014)
Dinaciclib (SCH727965) Inhibits the Unfolded Protein Response through a CDK1-and 5-Dependent Mechanism
Tri K. Nguyen et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains
Mathew P. Martin et al.
ACS CHEMICAL BIOLOGY (2013)
Cyclin-dependent kinase inhibitor therapy for hematologic malignancies
Prithviraj Bose et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Going further than Lipinski's rule in drug design
W. Patrick Walters
EXPERT OPINION ON DRUG DISCOVERY (2012)
A novel method for molecular dynamics simulation in the isothermal-isobaric ensemble
Cunkui Huang et al.
MOLECULAR PHYSICS (2011)
The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling
Jianing Li et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)
Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor
David Parry et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Identifying and Characterizing Binding Sites and Assessing Druggability
Thomas A. Halgren
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Benchmarking the reliability of QikProp. Correlation between experimental and predicted values
Leukothea Ioakimidis et al.
QSAR & COMBINATORIAL SCIENCE (2008)
Epik:: a software program for pK a prediction and protonation state generation for drug-like molecules
John C. Shelley et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Integrated modeling program, applied chemical theory (IMPACT)
JL Banks et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
分享论文
